⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9420725 | 0.74 | — | — | |
| SCHEMBL9420826 | 0.74 | — | — | |
| SCHEMBL16288121 | 0.73 | — | — | |
| SCHEMBL12571326 | 0.69 | — | — | |
| SCHEMBL7948237 | 0.69 | — | — | |
| SCHEMBL1014473 | 0.69 | — | — | |
| SCHEMBL21885944 | 0.69 | — | — | |
| SCHEMBL9885789 | 0.69 | — | — | |
| SCHEMBL1015589 | 0.67 | — | — | |
| SCHEMBL10577693 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 180 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0640142-B1 | PROCESS FOR PRODUCTION OF AVERMECTINS AND CULTURES THEREFOR | PFIZER (US) | 1998-05-20 | — | — | EP | claimed |
| EP-0276103-B1 | Process for production of B avermectins and cultures therefor | PFIZER (US) | 1993-10-20 | — | — | EP | claimed |
| EP-0284176-B1 | PROCESS FOR PRODUCTION OF AVERMECTINS AND CULTURES THEREFOR | PFIZER INC. (US) | 1993-08-25 | — | — | EP | claimed |
| EP-0313297-B1 | PROCESS FOR PRODUCTION OF AVERMECTIN AGLYCONES AND CULTURES THEREFOR | PFIZER INC. (US) | 1993-05-19 | — | — | EP | claimed |
| EP-0276131-B1 | NON-NATURAL DEMETHYLAVERMECTINS AND PROCESS THEREFOR | PFIZER INC. (US) | 1993-04-07 | — | — | EP | claimed |
| US-20170247416-A1 | Peptide with Safer Secondary Structure, Peptide Library, and Production Methods for Same | THE UNIVERSITY OF TOKYO (JP) | 2017-08-31 | — | — | US | disclosed |
| US-20170247416-A1 | Peptide with Safer Secondary Structure, Peptide Library, and Production Methods for Same | THE UNIVERSITY OF TOKYO (JP) | 2017-08-31 | — | — | US | disclosed |
| EP-2285775-B1 | Lactams and their use in the treatment of inter alia ocular hypertension or baldness | ALLERGAN INC (US) | 2017-03-22 | — | — | EP | disclosed |
| EP-1982978-B1 | PYRIDONE DERIVATIVE AND HERBICIDE | KUMIAI CHEMICAL INDUSTRY CO (JP) | 2014-08-27 | — | — | EP | disclosed |
| US-8633310-B2 | Therapeutic substituted lactams | ALLERGAN, INC. (US) | 2014-01-21 | — | — | US | disclosed |
| US-8569349-B2 | Therapeutic compounds | ALLERGAN, INC. (US) | 2013-10-29 | — | — | US | disclosed |
| US-20130245283-A1 | THERAPEUTIC AND DELIVERY METHODS OF PROSTAGLANDIN EP4 AGONISTS | ALLERGAN, INC. (US) | 2013-09-19 | — | — | US | disclosed |
| US-20070054893-A1 | Prostaglandin analogs | ALLERGAN, INC. | 2007-03-08 | — | — | US | disclosed |
| US-7179820-B2 | Piperidinyl prostaglandin E analogs | ALLERGAN, INC. (US) | 2007-02-20 | — | — | US | disclosed |
| US-6964976-B2 | Amino alcohol derivatives | SANKYO COMPANY, LIMITED (JP) | 2005-11-15 | — | — | US | disclosed |
| EP-1471054-A1 | AMINO ALCOHOL DERIVATIVE OR PHOSPHONIC ACID DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THESE | Sankyo Company, Limited (JP) | 2004-10-27 | — | — | EP | disclosed |
| US-20040132784-A1 | Amino alcohol derivatives | SANKYO COMPANY, LIMITED (JP) | 2004-07-08 | — | — | US | disclosed |
| US-6723745-B2 | PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE IN WARM BLOODED ANIMAL | SANKYO COMPANY, LIMITED (JP) | 2004-04-20 | — | — | US | disclosed |
| US-20030236297-A1 | Amino alcohol derivatives | SANKYO COMPANY, LIMITED (JP) | 2003-12-25 | — | — | US | disclosed |
| EP-1300405-A1 | AMINO ALCOHOL DERIVATIVES | Sankyo Company, Limited (JP) | 2003-04-09 | — | — | EP | disclosed |